Search

(EDGAR Online via COMTEX) -- ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and analysis of our financial condition and results of [...]

(EDGAR Online via COMTEX) -- 0001367644false00013676442024-11-062024-11-06 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act [...]

GREENBELT: Pomerantz LLP has issued the following press release: Pomerantz LLP announces that the United States District Court for the District of Maryland has approved the following announcement of a [...]

ENPNewswire-October 3, 2024--Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 02102024 - GAITHERSBURG - Emergent BioSolutions Inc. (NYSE: EBS) announced today that [...]

GAITHERSBURG: Emergent BioSolutions has issued the following news release: Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured approximately $400 million in orders in 2024 and 2025 associated with [...]

Emergent BioSolutions Inc. EBS said it bagged approximately $400 million in orders in 2024 and 2025 associated with its vaccinia, smallpox, and mpox product portfolio. The order includes the previously [...]

(EDGAR Online via COMTEX) -- Filed Pursuant to Rule 424(b)(4) Registration No. 333-281892 4,020,000 Shares of Common Stock 5,070,910 Pre-Funded Warrants to Purchase 5,070,910 Shares of Common Stock 18,181,820 Common [...]

GAITHERSBURG: Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded a contract modification executing an option period by the Biomedical Advanced Research and Development Authority (BARDA), part of [...]

GAITHERSBURG: Emergent BioSolutions has issued the following news release: Emergent BioSolutions Inc. (NYSE: EBS) ('Emergent' or the 'Company') today announced that it has entered into an agreement to resolve the [...]

GAITHERSBURG, Md: Emergent BioSolutions has issued the following news release: Today, Emergent BioSolutions Inc. (NYSE: EBS) announced it is kicking off the second year of the Ready to Rescue initiative, [...]

ENPNewswire-September 2, 2024--Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 30082024 - GAITHERSBURG, Md. - Today, Emergent BioSolutions Inc. [...]

GAITHERSBURG: Emergent BioSolutions Inc. (NYSE: EBS) announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for the expansion of the indication for [...]

(EDGAR Online via COMTEX) -- As filed with the Securities and Exchange Commission on August 30, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM [...]

Brenmiller Energy Ltd BNRG gained 96.2% to $1.32 in pre-market trading after the company reported a year-over-year increase in H1 EPS results. Also, the company announced a projected pipeline valued [...]

GAITHERSBURG, Md., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application [...]

GAITHERSBURG: Emergent BioSolutions has issued the following news release: Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2024. 'In the first half [...]

(EDGAR Online via COMTEX) -- ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and analysis of our financial condition and results of [...]

ENPNewswire-August 7, 2024--Emergent BioSolutions Reports Second Quarter 2024 Financial Results (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 06082024 - GAITHERSBURG - Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for [...]

ENPNewswire-August 7, 2024--Emergent BioSolutions Expands NARCAN Nasal Spray Distribution Capabilities to Enhance Customer Delivery Experience across the Country (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 06082024 - GAITHERSBURG - Emergent BioSolutions [...]

Second Quarter 2024 Total Revenues of $254.7 million, above the prior guidance range Second Quarter 2024 Net Loss of $283.1 million and Adjusted EBITDA of $(10.1) million Updates FY 2024 [...]

GAITHERSBURG: Emergent BioSolutions has issued the following news release: Emergent BioSolutions Inc. (NYSE: EBS) announced the sale of RSDL(r) (Reactive Skin Decontamination Lotion) kit to SERB Pharmaceuticals, a global pharmaceutical [...]

(GlobeNewswire) - Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the sale of RSDL (Reactive Skin Decontamination Lotion) kit to SERB Pharmaceuticals, a global pharmaceutical company, for a purchase price of [...]

ENPNewswire-August 1, 2024--Emergent BioSolutions Completes Sale of RSDL Kit to SERB Pharmaceuticals for $75 Million (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 31072024 - GAITHERSBURG - Emergent BioSolutions Inc. (NYSE: EBS) [...]

GAITHERSBURG, Md., July 31, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the sale of RSDL[sup.(R)] (Reactive Skin Decontamination Lotion) kit to SERB Pharmaceuticals, a global pharmaceutical [...]

GAITHERSBURG: Emergent BioSolutions Inc. announced the launch of a new opioid emergency awareness public education campaign to prepare people across the country to help save a life with the 'Lay, [...]

ENPNewswire-July 25, 2024--Emergent BioSolutions Launches Opioid Emergency Preparedness 'Lay, Spray, Stay' Public Education Campaign Starring Pro Football Hall of Famer Emmitt Smith (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 24072024 - [...]

GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss [...]

Shares of Emergent Biosolutions Inc (ER4) traded higher to a new 52-week high in today's trading. The stock is up 3.76% to EUR10.22 at the last check Monday. Emergent BioSolutions [...]

Shares of Emergent Biosolutions Inc (ER4) traded higher to a new 52-week high in today's trading. The stock is up 4.59% to 8.38 EUR at the last check Wednesday. Emergent [...]

(EDGAR Online via COMTEX) -- As filed with the Securities and Exchange Commission on June 26, 2024. Registration No. 333-280226 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT [...]

GAITHERSBURG, Md., June 20, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has entered into a definitive agreement to sell its drug product facility in [...]

(GlobeNewswire) - In recognition of National Naloxone Awareness Day, Emergent BioSolutions Inc. (NYSE: EBS) is highlighting its ongoing efforts to combat the opioid epidemic in the U.S., including topline results [...]

Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard of care for opioid overdose reversal in a community setting New topline survey findings [...]

2024 JUL 31 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and [...]

2024 JUL 24 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and [...]

2024 JUN 26 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and [...]

2024 JUN 26 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and [...]

2024 JUN 19 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and [...]

2024 JUN 12 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and [...]

Emergent BioSolutions Inc. EBS gained 72.1% to $3.32 in pre-market trading after the company announced operational changes to stabilize its financial position and reported first-quarter financial results. Aptevo Therapeutics Inc. [...]

GAITHERSBURG: Emergent BioSolutions Inc. (NYSE: EBS) today announced the results of a new national public opinion survey showing that more than 90 percent of Americans surveyed recognize opioid overdoses are [...]

Allarity Therapeutics, Inc. ALLR shares jumped 95% to $2.6801 after the company announced that Stenoparib shows a clear clinical benefit, leading to early conclusion of the Phase 2 trial in [...]

(GlobeNewswire) - Emergent BioSolutions Inc. (NYSE: EBS) today announced the results of a new national public opinion survey showing that more than 90 percent of Americans surveyed recognize opioid overdoses [...]

Nearly 9 in 10 Americans surveyed agree opioid overdoses are a concern for teenagers and college students; parents in the survey want life-saving treatment to be easily accessible in case [...]

ENPNewswire-April 23, 2024--Emergent BioSolutions to Release First Quarter 2024 Financial Results and Conduct Conference Call on May 1, 2024 (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 22042024 - GAITHERSBURG - Emergent [...]

GAITHERSBURG, Md., April 22, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, May 1, 2024, at 5:00 pm eastern time to discuss [...]

GAITHERSBURG: Emergent BioSolutions Inc. (NYSE: EBS) remains committed to fighting the ongoing opioid crisis by broadening access to and awareness of NARCAN(r) Nasal Spray to help save lives in opioid [...]